Skye Bioscience, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
35.1M
on 2026-06-30, from 28.1M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
S-3 of 2024-05-10. Not read yet. S-3 ↗
2 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-14 is not read yet.
Cash
1 quarters
$10.1M on 2026-06-30 ÷ $9.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | Private placement | not read | not read | $67.9M | 8-K ↗ |
Also on file: a 1-for-8 reverse split, 2026-08-12 8-K ↗